EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Patient stratification for dose scaling in cervical cancer: a model-based analysis using image-guided adaptive brachytherapy

Tenyoh Suzuki iD, Ryo Takahashi, Hidenobu Tachibana iD, Shioto Oda, Takeshi Fujisawa, Masaki Nakamura iD, Hidehiro Hojo, Kento Tomizawa, Weishan Chang, Tetsuo Akimoto, Sadamoto Zenda iD

Journal of Radiation Research · 24.07.2026 · 67 (4) · 665-672

DOI: 10.1093/jrr/rrag047 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Radiation Research, online erschienen am 07.07.2026. Verfasst von Tenyoh Suzuki und 10 weiteren Autor:innen. Beteiligte Einrichtung: Section of Radiation Safety and Quality Assurance, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa, Chiba 277-8577, Japan. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Brachytherapy, Radiotherapy, Image-Guided. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The purpose of this study was to identify the characteristics of cervical cancer patients who benefit most from dose scaling (DS) using a model-based approach in image-guided adaptive brachytherapy (IGABT). We retrospectively analyzed 57 cervical cancer patients who underwent IGABT and external beam radiotherapy. Model-based DS was simulated to increase the brachytherapy dose until predefined normal tissue complication probability thresholds were reached. Clinically significant therapeutic gain was predefined as a tumor control probability (TCP) increase of greater than 3%, consistent with prior radiobiological modeling studies. Patient characteristics were compared between groups with and without significant TCP gain. Of the 53 patients in whom dose escalation was feasible, 16 (30.2%) achieved a significant TCP gain. A significant gain was strongly associated with histopathological type and magnetic resonance imaging (MRI) findings. All four patients (100%) with adeno/adenosquamous carcinoma (AdSq) achieved a significant gain, compared with only 12 of 49 (24.5%) with squamous cell carcinoma (P = 0.006). Uterine corpus invasion (UCI) on MRI was also a significant predictor of benefit (P < 0.001). Conversely, larger high-risk clinical target volume limited the potential for dose increase. AdSq cases demonstrated substantial improvement, with TCP increases after DS often exceeding 10%. Patients with poor prognostic features on MRI, specifically UCI, and those with histological AdSq may benefit most from DS in IGABT for cervical cancer. This exploratory study suggests that model-based DS shows promise for personalized treatment planning, supporting a shift from fixed-dose prescriptions toward strategies tailored to individual patient and tumor characteristics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsBrachytherapyRadiotherapy, Image-GuidedHumansFemaleRadiotherapy DosageMiddle AgedAgedAdultRetrospective StudiesRadiotherapy Planning, Computer-AssistedTreatment OutcomeMagnetic Resonance ImagingAged, 80 and over

Stichwörter der Autor:innen

brachytherapydose scalingpersonalized medicinetreatment planningtumor control probability

Autor:innen und Institutionen

  • Section of Radiation Safety and Quality Assurance, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa, Chiba 277-8577, Japan.
  • Department of Radiological Sciences, Tokyo Metropolitan University, 7-2-10 Higashi-Ogu, Arakawa-ku, Tokyo 116-8551, Japan.
  • Department of Diagnostic Radiology, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa, Chiba 277-8577, Japan.
  • Department of Radiation Oncology, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa, Chiba 277-8577, Japan.

ORCID-Profile: Tenyoh Suzuki, Hidenobu Tachibana, Masaki Nakamura, Sadamoto Zenda

Zitieren

APA

Suzuki, T., Takahashi, R., Tachibana, H., Oda, S., Fujisawa, T., Nakamura, M., Hojo, H., Tomizawa, K., Chang, W., Akimoto, T., & Zenda, S. (2026). Patient stratification for dose scaling in cervical cancer: a model-based analysis using image-guided adaptive brachytherapy. Journal of Radiation Research, 67(4), 665-672. https://doi.org/10.1093/jrr/rrag047

Vancouver

Suzuki T, Takahashi R, Tachibana H, Oda S, Fujisawa T, Nakamura M, et al. Patient stratification for dose scaling in cervical cancer: a model-based analysis using image-guided adaptive brachytherapy. Journal of Radiation Research. 2026;67(4):665-672. doi:10.1093/jrr/rrag047

BibTeX
@article{Suzuki2026,
  author = {Suzuki, Tenyoh and Takahashi, Ryo and Tachibana, Hidenobu and Oda, Shioto and Fujisawa, Takeshi and Nakamura, Masaki and Hojo, Hidehiro and Tomizawa, Kento and Chang, Weishan and Akimoto, Tetsuo and Zenda, Sadamoto},
  title = {Patient stratification for dose scaling in cervical cancer: a model-based analysis using image-guided adaptive brachytherapy},
  journal = {Journal of Radiation Research},
  year = {2026},
  volume = {67},
  number = {4},
  pages = {665--672},
  doi = {10.1093/jrr/rrag047}
}
Kostenlos starten →